Records containing: Psoriasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-04-06Evaluation Of Levels Of Pigment Epithelium-Derived Factor (PEDF) In Patients With Psoriasis.
-
CLINICAL_TRIALS study record update · 2022-03-31Spanish Registry of Systemic Treatments in Psoriasis
-
CLINICAL_TRIALS study record update · 2022-03-25Bioequivalence Randomised, Double-blind, 3-parallel -Group Phase I Study of BFI-751 Compared With EU-STELARA® and US-STELARA® in Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2022-03-23Expression of the JAK-STAT Signaling Pathway in Pyoderma Gangrenosum Pathological Biopsy
-
CLINICAL_TRIALS study record update · 2022-03-15A Multiple-Dose, Randomized, Placebo-Controlled, Study of LY3462817 or LY3509754 in Patients With Psoriasis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-03-11Multicenter, Double-Blind, Randomized, 2-Arm, Parallel-Group, Equivalence Study Evaluating Efficacy and Safety Similarity of Mylan Adalimumab (MYL-1401A) Compared With Humira® in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2022-02-09A Double-Blind, Randomized, Vehicle-Controlled Dose Ranging Study of the Effect of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2022-02-08An Open Label, Safety, Tolerability, Pharmacokinetic (PK), Pharmacodynamic (PD) and Preliminary Efficacy Study of Ruxolitinib When Applied to Patients With Plaque Psoriasis Involving 2 - 20% Body Surface Area (BSA).
-
CLINICAL_TRIALS study record update · 2022-02-08Long-term Documentation of the Utilization of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions (LAPIS-Pso)
-
CLINICAL_TRIALS study record update · 2022-02-08A Double-Blind, Vehicle-Controlled, Rising Dose, Safety, Tolerability, Pharmacokinetic and Preliminary Efficacy Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2022-02-07An Observational Study Evaluating the Utility of Ultrasound Confirmed Enthesitis as a Prognostic Marker for Response to Biologic Therapy in Psoriatic Arthritis
-
CLINICAL_TRIALS study record update · 2022-02-04Supporting Health Care Professionals in Hospital and Primary Care to Promote Adequate HIV Risk and Indicator Condition Driven Testing in Routine Care.
-
CLINICAL_TRIALS study record update · 2022-02-02Evaluation of a Therapeutic Education Program in Patients With Moderate to Severe Psoriasis : a Multicenter Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2022-01-28Neuroinflammation and Affective and Cognitive Symptoms in Patients Suffering From Major Depression and Psoriasis and Their Evolution With Treatment: A Prospective Study
-
CLINICAL_TRIALS study record update · 2022-01-25A Safety, Tolerability, Pharmacokinetic, and Efficacy Study of ABY-035/AFO2 Given as Multiple Doses in Sequential Escalating Dose Cohorts in Psoriasis Subjects
-
CLINICAL_TRIALS study record update · 2022-01-24Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin
-
CLINICAL_TRIALS study record update · 2022-01-14Impact of COVID-19 on Psoriasis Practice: A Cross Sectional Study
-
CLINICAL_TRIALS study record update · 2022-01-13A Phase 4, Multi-center, Randomized, Double-blind, Placebo-controlled Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Subjects With Manifestations of Plaque Psoriasis and Impaired Quality of Life
-
CLINICAL_TRIALS study record update · 2022-01-11Videocapillaroscopy Assessment During Systemic Agent Therapy in Patients With Psoriasis
-
CLINICAL_TRIALS study record update · 2022-01-10A Phase 1 Randomized Double-Blind Placebo-controlled Single and Multiple Ascending Dose Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis or Atopic Dermatitis
-
CLINICAL_TRIALS study record update · 2022-01-06Monitoring Nail Changes in Patients With Psoriatic Disease Treated With Etanercept Using Non- Invasive Optical Coherence Tomography
-
CLINICAL_TRIALS study record update · 2022-01-03A Phase 3b, Multicenter, Interventional, Randomized, Placebo-controlled Study Investigating the Efficacy and Safety of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis
-
CLINICAL_TRIALS study record update · 2021-12-15Sleep, Circadian Rhythm & Skin Health
-
CLINICAL_TRIALS study record update · 2021-12-03Real Life Data for Otezla Evidence: Assessing Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France
-
CLINICAL_TRIALS study record update · 2021-12-03Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines Using Delphi Consensus Statement